Interleukin-2 shows high adjuvanticity for an inactivated vaccine against duck Tembusu virus disease

Currently, the widely used vaccine against duck Tembusu virus (DTMUV) disease is inactivated vaccine which, however, facing the limits of large inoculation dose, short immunization period, and incomplete effectiveness. Access to efficient adjuvants aiding for DTMUV inactivated vaccine seems to be of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xintao, Ren, Xiao, Zhang, Shan, Song, Haozhi, Guo, Xiaoyu, Jia, Hong, Xin, Ting, Jiang, Yitong, Zhang, Zhifang, Hou, Shaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Immunology, Health and Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704720/
https://www.ncbi.nlm.nih.gov/pubmed/33248560
http://dx.doi.org/10.1016/j.psj.2020.08.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704720/
https://www.ncbi.nlm.nih.gov/pubmed/33248560
http://dx.doi.org/10.1016/j.psj.2020.08.022

Ejemplares similares